Navigation Links
Accentia announces investigational new drug application for Revimmune for refractory MS
Date:10/9/2007

TAMPA, FL(October 9, 2007)Accentia Biopharmaceuticals announces that it met with the Food and Drug Administration (FDA) on September 26, 2007 for a scheduled pre-Investigational New Drug (pre-IND) meeting on Revimmune. The FDA has indicated its support for Accentia to submit an IND for a pivotal Phase 3 randomized controlled, multi-center clinical trial of Revimmune, the companys potential therapeutic for refractory, relapsing-remitting Multiple Sclerosis (MS). The FDA indicated that they support the proposed submission from Accentia and that they are in overall agreement with the proposed design of the Accentia clinical program.

The Revimmune MS study will enroll subjects in a one-year study comparing baseline disability to disability at month 12 with an interim data analysis. After consultation with the FDA on the design of the trial, it was agreed that the primary endpoint will be recovery of lost function and that this unique study will be done under a special protocol assessment (SPA). Accentia will proceed diligently with submission of the IND under a SPA and of an application for Fast Track status, and currently projects commencement of the Phase 3 study in the first half of 2008. A Special Protocol Assessment is a declaration from the Food and Drug Administration that a proposed Phase 3 trial 's design, clinical endpoints, and statistical analyses are acceptable for FDA approval. All prior approved therapeutics suppress rather than eliminate autoimmunity and they have used the more limited indication of a reduction in the rate of progression of disability as their primary endpoint, not a reduction in disability as for Revimmune.

Revimmune is the first drug to propose restoration of lost function in MS patients. Using a patent-pending, ultra-high intensity, short-course of an intravenous formulation of cyclophosphamide, Revimmune is intended to reboot a patients immune system, thereby eliminating autoimmunity, whereas current ther
'/>"/>

Contact: Adam Holdsworth
aholdsworth@investorrelationsgroup.com
212-825-3210
The Investor Relations Group
Source:Eurekalert

1

GOOD

Page: 1 2 3

Related medicine news :

1. New lease of life for asthmatics by Accentia Biopharmaceuticals
2. PM announces a new health care order for India
3. Ramdoss Announces Introduction of RCH-II
4. Britain Announces Third Transfusion Related Mad Cow Case
5. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
6. Tibet Announces the Dalai Lama’s Tour of South Americ
7. NHS announces further Cost cutting Measures
8. Indian PM Announces Of Setting Up India Study Center At Tashkent
9. PowderMed Announces Needle-Less Flu Vaccine
10. Malaysia Announces Prison term On People Donating HIV-Contaminated Blood
11. Australian Government Announces Survey To Tackle Childhood Obesity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2013)... (May 18, 2013) A ground-breaking advance in ... according to research presented today at Digestive Disease ... minimal withdrawal time for colonoscopies and exploring safer ... colonoscopy, doctors use a device called a colonoscope ... colorectal cancer allows a doctor to look for ...
(Date:5/18/2013)... May 18, 2013 The “World Healthcare ... and studies the major market drivers, restraints, and opportunities ... world. , Browse , 89 ... in-depth TOC on "Healthcare IT Market" , ... customization on reports. , The global healthcare IT market ...
(Date:5/18/2013)... May 18, 2013 During Better Hearing ... should consider the legal protections they have, including the ... arise with their child’s treatment or hearing aid device, ... 1927, the American Speech-Language-Hearing Association has used the month ... to promote treatment, such as cochlear implants, which can ...
(Date:5/18/2013)... Adolescents, especially young males, who experiment with synthetic ... landing in emergency rooms across America. Recovery ... with a new treatment program for those addicted to ... the National Institute on Drug Abuse, synthetic marijuana has ... In 2012, 11 percent of high school seniors had ...
(Date:5/18/2013)... 2013 The American Society for ... Kitzhaber, M.D., (D) to sign a bill (HB 2896) ... under the age of 18 from tanning indoors. , ... state in the nation to enact an under-18 tanning ... tanning bans for minors. Nationwide, 34 states and the ...
Breaking Medicine News(10 mins):Health News:New colonoscope provides ground-breaking view of colon 2Health News:New colonoscope provides ground-breaking view of colon 3Health News:New colonoscope provides ground-breaking view of colon 4Health News:Healthcare IT Market to reach US$ 162.2 Billion by 2015 at a CAGR of 10.2% - New Report by MarketandMarkets 2Health News:Healthcare IT Market to reach US$ 162.2 Billion by 2015 at a CAGR of 10.2% - New Report by MarketandMarkets 3Health News:Schachter, Hendy & Johnson PSC Lawyer Says Cochlear Implant Victims Should Know Their Legal Rights 2Health News:Schachter, Hendy & Johnson PSC Lawyer Says Cochlear Implant Victims Should Know Their Legal Rights 3Health News:Spice Addiction Treatment and Synthetic Marijuana Drug Rehab Announced by Recovery Associates 2Health News:ASDSA Urges Oregon Governor to Sign Under-18 Indoor Tanning Restrictions 2
... live but weakened versions of the H5N1 bird flu virus ... the solution to to stockpile vaccines ahead of a pandemic. ... underway, and this could lead to the start of a ... ,The researchers wrote in the online journal ...
... the largest number of polio cases. According to a senior ... abroad are spreading the disease. ,"Investigation of strains ... in the African countries of Congo and Mozambique has revealed ... Polio Coordinator for Uttar Pradesh. ,Nearly, 280 cases ...
... is natural for a patient to tread carefully, fearing ... overriding emotions// after a heart attack, which cannot be ... occasion to allay the doubts and uncertainties that ebb ... ,Often, ambiguous communication from caregivers cause more harm than ...
... fined American Red Cross a record $4.2 million for ... other safety problems//. ,The Food and Drug Administration ... in previous fines since 2003, calling attention to a ... Cross is a humanitarian organization which depends heavily on ...
... PLC, a company that manufactures a lot of skincare products, ... killing the H5N1 bird flu virus in 30 seconds.// ... Retroscreen Virology Ltd, a European contract Virology research company for ... Solutions Limited ('DDS'). ,It also said that the ...
... Nicole's drastic weight loss that he agreed to take her to ... to contactmusic.com, Richie was scared for his daughter's health and wanted ... ,He says: "Believe me, I've checked it out three different ways ... said, 'Okay, what is it?' Is it really an eating disorder?' ...
Cached Medicine News:Health News:Vaccine Made from Live bird flu virus vaccine Offers Protection to Animals 2Health News:American Red Cross Fined $4.2m for Improper Blood Screening 2
(Date:5/16/2013)... Mass. and SYDNEY , May ... - ASX: HIN), a leading innovator of less invasive, ... advanced heart failure, today announced that CEO Doug ... UBS Global Healthcare Conference at 11:00 a.m. EDT on Monday, ... 2013 at the Sheraton New York Hotel. A ...
(Date:5/16/2013)... May 16, 2013 AcelRx Pharmaceuticals, Inc. (Nasdaq: ... development and commercialization of innovative therapies for the treatment of ... King , President and CEO, will present a corporate ... New York Hotel in New York , ... at 9:30 a.m. ET/6:30 a.m. PT. The presentation ...
(Date:5/16/2013)... -- Developers of a pill bottle that wirelessly transmits data, ... prize winners in the Healthcare Innovation World Cup , ... organized by HITLAB . Winning team members ... and Mike Morena of ... will receive $50,000 in prize money. They earned ...
Breaking Medicine Technology:HeartWare Presentation At The 2013 UBS Global Healthcare Conference To Be Webcast 2AcelRx Pharmaceuticals to Present at the UBS Global Healthcare Conference 2AcelRx Pharmaceuticals to Present at the UBS Global Healthcare Conference 3Wireless Pill Bottle Wins Healthcare Innovation World Cup 2Wireless Pill Bottle Wins Healthcare Innovation World Cup 3Wireless Pill Bottle Wins Healthcare Innovation World Cup 4Wireless Pill Bottle Wins Healthcare Innovation World Cup 5
... 2011 MediSapiens Ltd , a Finnish ... gene expression yet for public use. The data is available ... home page of MediSapiens Ltd , allowing exploration of ... healthy human tissues. Since the sequencing of the human genome, ...
... SAN CARLOS, Calif. and SAN DIEGO, Sept. 29, 2011 ... maternal and fetal health, today announced it has signed ... developer and manufacturer of life sciences tools for the ... Under the terms of the agreement, Verinata Health will ...
Cached Medicine Technology:Transcriptome Viewer - Comprehensive Genome-wide Map of Human Gene Expression Activity Released for Public by MediSapiens 2Verinata Health Announces a Multi-Year Supply Agreement with Illumina in the Field of Non-Invasive Prenatal Diagnostics 2
... Spot Vital Signs device ... seconds. The basic unit ... pulse rate and mean ... Vital Signs additional parameters ...
... CS offers the features needed for quality, ... 8.4-inch TFT color display allows you to ... vectors of ECG. The touch screen allows ... impaired by gloves or temperature., ,Standard ...
... The Acuity LT Central Monitoring Station ... self-contained and ready to go right out ... patient surveillance in specific care areas rather ... the ICU. As patient-to-caregiver ratios continue to ...
... the smallest handheld oximeters available, Datex-Ohmeda s ... hospital, home care, transport, and EMS. TuffSat ... ,PIr (relative perfusion index measurement) a ... numeric reflection of perfusion at the sensor ...
Medicine Products: